Ignite Creation Date:
2025-12-24 @ 7:58 PM
Ignite Modification Date:
2026-07-16 @ 10:43 PM
Study NCT ID:
NCT05431504
Status:
NOT_YET_RECRUITING
Last Update Posted:
2022-06-24
First Post:
2022-06-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
The Efficacy and Safety of Dalpiciclib Plus Endocrine Therapy in HR-positive / HER2-negative Advanced Breast Cancer Patients With Visceral Crisis
Sponsor:
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Advanced Breast Cancer | View |
Keywords: